Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

12/08/2016 07:00

Aug 12 (Reuters)-  
             Shin Nippon Biomedical Laboratories Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended        Year to   
                  Jun 30, 2016        Jun 30, 2015      Mar 31, 2017   
                     LATEST             YEAR-AGO           LATEST      
                     RESULTS             RESULTS          FORECAST     
  Sales               3.39                3.22              16.50      
                   (+5.3 pct)          (-17.3 pct)       (+11.9 pct)   
  Operating       loss 947 mln          loss 1.35         loss 2.25    
  Recurring         loss 1.80           loss 1.15         loss 2.78    
  Net               loss 1.78             2.34            loss 2.92    
  EPS            loss 44.21 yen         58.88 yen      loss 70.72 yen  
  EPS Diluted                           58.02 yen                      
  Ann Div                                  NIL                         
  -Q2 div                                  NIL                         
  -Q4 div                                  NIL                         
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T  
  ((Tokyo Headline News Desk +813 6441 1812))